Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.31.1 (
micrococcal nuclease
)
2,818
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
STAT6
is a central mediator of IL-4-induced gene responses.
STAT6
-mediated transcription is depend ent on the C-terminal transcription activation domain (TAD), but the mechanisms by which
STAT6
activates transcription are poorly understood. Here, we have identified the
staphylococcal nuclease
(SN)-like domain and tudor domain containing protein p100 as a
STAT6
TAD interacting protein. p100 was originally characterized as a transcriptional coactivator for Epstein-Barr virus nuclear antigen 2.
STAT6
interacted with p100 in vitro and in vivo. The interaction was mediated by the TAD domain of
STAT6
and the SN-like domain of p100. p100 did not affect the immediate activation events of
STAT6
, but enhanced
STAT6
-mediated transcriptional activation and the IL-4-induced Igepsilon gene transcription in human B-cell line. Finally, p100 associated with the large subunit of RNA polymerase II and was mediating interaction between
STAT6
and RNA polymerase II. These findings identify p100 as a novel coactivator for
STAT6
and suggest that p100 functions as a bridging factor between
STAT6
and the basal transcription machinery.
...
PMID:Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. 1223 34
STAT6
is a critical regulator of transcription for interleukin-4 (IL-4)-induced genes. Activation of gene expression involves recruitment of coactivator proteins that function as bridging factors connecting sequence-specific transcription factors to the basal transcription machinery, and as chromatin-modifying enzymes. Coactivator proteins CBP/p300 have been implicated in regulation of transcription in all STATs. CBP is also required for
STAT6
-mediated gene activation, but the underlying molecular mechanisms are still elusive. In this study we investigated the mechanisms by which
STAT6
recruits CBP and chromatin-modifying activities to the promoter. Our results indicate that while STAT1-interacted directly with CBP, the interaction between
STAT6
and CBP was found to be mediated through p100 protein, a coactivator protein that has previously been shown to stimulate the transcription of IL-4-induced genes. The
staphylococcal nuclease
-like (SN)-domains of p100 directly interacted with amino acids 1099-1758 of CBP, while p100 did not associate with SRC-1, another coactivator of
STAT6
. p100 was found to recruit histone acetyltransferase (HAT) activity to
STAT6
in vivo. Chromatin immunoprecipitation studies demonstrated that p100 increases the
STAT6
-p100-CBP ternary complex formation in the human Igepsilon promoter. p100 also increased the amount of acetylated histone H4 at the Igepsilon promoter, and siRNAs directed against p100 effectively inhibited Igepsilon reporter gene expression. Our results suggest that p100 has an important role in the assembly of
STAT6
transcriptosome, and that p100 stimulates IL-4-dependent transcription by mediating interaction between
STAT6
and CBP and recruiting chromatin modifying activities to
STAT6
-responsive promoters.
...
PMID:The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. 1569 2